FONT-SIZE Plus   Neg

KineMed And Pfizer Extend Collaboration On Type II Diabetes - Quick Facts

KineMed Inc. announced the renewal of a non-exclusive research collaboration with Pfizer Inc. (PFE) for the advancement of novel approaches in metabolic disease, in particular Type II diabetes.

KineMed stated that the collaboration employs its novel dynamic proteomics technology platform to map the impact of potential drug candidates on specific metabolic pathways.

"This platform has been useful in accelerating advancement and de-risking compounds in Type II diabetes. We look forward to continuing our work with Pfizer on their compounds in preclinical and clinical trials," said Marc Hellerstein, President, Chief Science Officer and Co-founder at KineMed.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Target's website crashed for short period due to the heavy traffic of Cyber Monday, the biggest online shopping day of the year. It's another sign that consumers are growing completely confortable with shopping online instead of braving the holiday shopping season crowds at brick-and-mortars. Target's... Global watch maker, Swatch Group will be launching "pay by the wrist" watches early next year in partnership with Visa Inc. Wal-Mart Stores, Inc. (WMT) Tuesday said nearly half of its orders since Thanksgiving have been placed on a mobile device, double compared to last year. Star Wars toys, 4K HDTVs 50-55", drones, Xbox One and PS4 video game bundles, iPad Minis and 14-ft. trampolines were among the categories that gained...
comments powered by Disqus
Trade PFE now with 
Follow RTT